Back Pain Doctor
Iliotibial (IT) Band Syndrome
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Iliotibial (IT) band syndrome is a common cause of pain on the outside of the knee (and sometimes the hip) in runners, cyclists and other athletes. It is an overuse problem, usually triggered by training errors such as a sudden increase in distance or intensity, too little recovery, or running on uneven or cambered surfaces. Factors like weak hip and buttock muscles or reduced flexibility can contribute.
Assessment confirms the diagnosis, checks for contributing factors in the hip, leg and foot, and rules out other causes of lateral knee pain such as arthritis when the picture is unclear. Imaging is not usually required: this fits Choosing Wisely Australia advice against routine imaging for uncomplicated musculoskeletal pain.
The mainstay of treatment is load management and a progressive strengthening program, particularly for the hip abductor and gluteal muscles, alongside relative rest and, where appropriate, a short course of anti-inflammatory medication. For cases that persist despite appropriate rehabilitation, adjuncts such as focused shockwave therapy may be discussed, with the evidence set out. Most people recover without needing surgery.
Common symptoms
- Aching or burning on the outside of the knee, sometimes the hip
- Pain that comes on with running or cycling and eases with rest
- Pain worse running downhill or on cambered surfaces
- Occasional clicking on the outside of the knee or hip
Commonly seen in
Evidence for twelve treatment options in iliotibial (it) band syndrome
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Loading is the treatment, and the trials say adjuncts add little to it. A living network meta-analysis of 68 randomised trials across Achilles and patellar tendinopathy and gluteal tendinopathy found no convincing evidence that any adjunct, alone or added to exercise, beats exercise by itself, and recommended exercise alone for at least three months before an adjunct is considered (Challoumas, Sports Med Open 2023). A meta-analysis of 110 studies and 3,953 patients found greater effect where the programme added external load rather than body weight alone, and where sessions were less frequent than daily, allowing recovery (Pavlova, Br J Sports Med 2023). A 204-study synthesis found exercise safe, beneficial and acceptable to patients, with no clear superiority for the eccentric-only protocols long treated as standard (Cooper, Health Technol Assess 2023).
Pairing reviewed 2026-09-02.
Where it fits
This is the plan, not the preliminary. Expect a programme measured in months rather than weeks, with load progressed against your symptoms. Anything else offered here is an adjunct to it, and the evidence for adding one before three months of proper loading is weak.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Dry needling trials only
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
Searched 18 October 2026: iliotibial with needling, trigger point, acupotomy, needle knife or wet needling (8 records, all read). No trial of wet needling or trigger point injection in this condition. The nearest evidence is dry needling, a different procedure: in 40 adults with this condition, dry needling plus stretching lowered pain from 9.0 to 1.8 out of 10 four weeks after treatment, ahead of radial shockwave (3.6), with no difference in function (Maghroori, Galen Med J 2021), and in 38 athletes with a tight iliotibial band (not a confirmed diagnosis of this syndrome), three sessions of dry needling with stretching beat stretching alone straight after treatment (Singh, J Bodyw Mov Ther 2024). Neither trial had a sham. A 24-study review mentions a needling trial against cortisone that this search did not find (Ferrero, Orthop Res Rev 2026).
Pairing reviewed 2026-10-18.
Where it fits
Considered where examination finds a tender muscle band in the outer thigh or hip contributing to the pain, as an adjunct to the loading program.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. One small trial, two weeks
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
One small randomised trial: in 18 runners with iliotibial band syndrome of less than two weeks, 40 mg methylprednisolone with local anaesthetic, injected where the band crosses the outer knee, reduced pain during a treadmill run more than local anaesthetic alone between day 7 and day 14 (p = 0.01; p = 0.07 at day 7). Follow-up ended at two weeks, and the injection was not ultrasound-guided (Gunter, Br J Sports Med 2004). In an older series of 100 knees in runners, 30 settled with one steroid injection and reduced training, and 29 needed a second or third (Noble, Am J Sports Med 1980). A case report describes rupture of the iliotibial band after several steroid injections (Pandit, Mil Med 2014). A 2007 systematic review found limited evidence that any conservative treatment helps (Ellis, Man Ther 2007).
Pairing reviewed 2026-10-30.
Where it fits
Load management and hip and knee strength work come first. For a recent flare that is stopping running, a single guided injection under the band may be discussed for short-term relief, with the number kept low. See the note on cortisone.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. Two small trials, no sham
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searched 18 October 2026: shockwave, shock wave, ESWT or pressure wave with iliotibial, IT band or ITBS (10 records), and a systematic-review pass on the iliotibial band (53 records), all read. The old line here said the trials used focused devices; both trials in this condition used radial. In 24 runners, all doing an exercise program, three weekly sessions of radial shockwave reduced running pain by 51% at four weeks and 75% at eight, level with manual therapy (Weckström, J Back Musculoskelet Rehabil 2016). In 40 adults, both groups stretching, four weekly sessions lowered pain from 8.3 to 3.6 out of 10 four weeks after treatment, but dry needling did better (1.8, P = 0.023), with no difference in function and no complications in either group (Maghroori, Galen Med J 2021; allocation by odd and even number). Neither trial had a sham or exercise-only group, so whether shockwave adds anything to exercise here is not known (Ferrero, Orthop Res Rev 2026, a review of 24 studies).
Pairing reviewed 2026-10-18.
Where it fits
Can be discussed as an adjunct to a hip-strengthening and running-load program when outer-knee pain has not settled. In the two trials it did about as well as hands-on therapy and less well than dry needling.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. No focused-device trial
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
Searched 18 October 2026 (the searches named in the radial row: 10 shockwave records and 53 systematic-review records on the iliotibial band): no trial of a focused device in this condition. Both trials used radial shockwave (Weckström, J Back Musculoskelet Rehabil 2016; Maghroori, Galen Med J 2021), and a 24-study systematic review found no evidence that any device treatment adds to exercise here (Ferrero, Orthop Res Rev 2026).
Pairing reviewed 2026-10-18.
Where it fits
Plausible where the band's attachment near the knee is the tender point, and can be discussed on that basis, but patients are told the trials in this condition used the radial device.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. One small placebo-controlled trial
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
One randomised trial, and it is positive. Sixty people aged 18 to 50 whose iliotibial band syndrome had not settled after at least twelve weeks of conservative treatment had a single ultrasound-guided injection of PRP or saline at the outer knee, with patients and assessors blinded. At six months pain had fallen by 4.7 points out of 10 with PRP against 2.5 with saline, function scores were higher, and 83% against 57% were back at their previous sport. There were no serious side effects, and short-lived soreness after the injection was a little more common with PRP, 17% against 10% (Elazab, Apunts Sports Med 2026). The limits are real: one hospital, six months of follow-up, no registration in advance, and about one in eight participants missing at the end. A systematic review of 24 studies of this condition calls the result promising but not yet repeated by anyone else, notes that PRP was never compared with a rehabilitation program, and keeps structured rehabilitation as the first treatment (Ferrero, Orthop Res Rev 2026). The trial does not apply to newly diagnosed pain.
Pairing reviewed 2026-10-10.
Where it fits
Rehabilitation comes first: hip strengthening, changes to running load and time settle most cases. For pain that has persisted beyond about three months of a proper program, an ultrasound-guided PRP injection can be discussed as a way of getting back to loading, on the understanding that it rests on a single trial of 60 people.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. No study in this condition
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No study of prolotherapy in iliotibial band syndrome. A 2026 systematic review of 24 studies and 1,012 people with this condition states that it found no evidence specific to iliotibial band syndrome for prolotherapy (Ferrero, Orthop Res Rev 2026). PubMed searches on 16 October 2026 (prolotherapy, dextrose, hypertonic glucose or hyperosmolar with iliotibial, IT band, ITB or lateral knee pain) returned two records, neither a study of dextrose in this condition, and passes restricted to randomised trials and to systematic reviews found only that review. The injection trials in this condition tested cortisone and PRP, not dextrose.
Pairing reviewed 2026-10-16.
Where it fits
Can be discussed where pain at the outer knee persists despite a well-run program of load management and hip strengthening, with the absence of studies stated. It sits alongside that program, not in place of it.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. Not used for tendons
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Not offered here, and not studied. A 2026 systematic review of 24 studies and 1,012 people with iliotibial band syndrome found no controlled study of hyaluronic acid in this condition (Ferrero, Orthop Res Rev 2026), and PubMed searches pairing hyaluronic acid with iliotibial terms found no other treatment study. This is an absence of evidence, not evidence that it fails.
Pairing reviewed 2026-11-09.
Where it fits
Not offered for this problem. Hyaluronic acid is considered only for a problem inside a joint, and this pain arises outside the knee joint. Rehabilitation comes first, and PRP has the stronger evidence for pain that persists.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
A PubMed search for dextrose, prolotherapy, perineural injection or hydrorelease combined with iliotibial band syndrome, runner's knee or lateral knee pain returns one record, a case report of ischiofemoral impingement treated with a different injectate. No study of any design has tested perineural injection at the lateral knee.
Pairing reviewed 2026-09-09.
Where it fits
Not offered for the band itself. Iliotibial band syndrome is a compression problem at the lateral femoral condyle and it responds to running volume and cadence changes, hip abductor strength and time. An injection around a superficial nerve would only be considered if the lateral knee skin proved hypersensitive on examination.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Searching hydrodissection and hydrorelease against the iliotibial band and iliotibial band syndrome returns no records, so the technique has not been reported at this site. A scoping review that screened 138 studies of hydrodissection and hydrodilatation for joint pain found its signals in adhesive capsulitis, greater trochanteric pain syndrome and knee osteoarthritis, and does not cover the iliotibial band (Leahy, Front Pain Res 2026).
Pairing reviewed 2026-09-15.
Where it fits
Only where the assessment finds a nerve contributing separately to the outer knee or thigh pain; the common peroneal nerve at the fibular head is the one that sits close enough to be confused with this. The iliotibial band problem itself is a loading problem and is treated by the options higher up this page.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other knee conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
How is IT band syndrome diagnosed?
What is the main treatment?
How long does it take to settle?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment